Most Recent
Boehringer appeals failed opposition to Zoetis patents
Intellectual Property 2020-09-21 3:11 pm By Cat Fredenburgh

German drug maker Boehringer has launched a Federal Court fight against rival Zoetis after coming up short in its opposition to two Zoetis patents for pig vaccine-related inventions.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ACCC calls for $3.5M penalty for Oscar Wylee’s ‘brazen’ charity misrepresentations
Competition & Consumer Protection 2020-09-15 7:46 pm By Alison Eveleigh

The ACCC has asked a court to impose a $3.5 million penalty against eyewear retailer Oscar Wylee for making misleading representations about its charitable donations and affiliations, including that it would donate one pair of eyeglasses to charity for every pair purchased.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Nthalmic directors accused of misusing confidential information in lens patent applications
Intellectual Property 2020-09-15 6:10 pm By Miklos Bolza

Sydney-based research foundation Brien Holden Vision Institute has filed a lawsuit alleging three senior researchers misused confidential information when they jumped ship to a rival research group and filed applications to patent seven inventions for opthalmic lenses designed to treat myopia allegedly based on that information.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Mylan NV’s planned merger with Pfizer’s Upjohn gets greenlight after drug sell-off
Corporate 2020-09-10 3:50 pm By Alison Eveleigh

The competition watchdog will not oppose Mylan NV’s proposed merger with Pfizer’s Upjohn Inc after the global pharmaceutical giants agreed to sell several off-patent brands to dispel competition concerns.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharpe & Dohme sues Lupin over Januvia patent
Intellectual Property 2020-09-07 2:44 pm By Cat Fredenburgh

US pharmaceutical giant Merck Sharp & Dohme has taken a unit of Indian generic manufacturer Lupin to court for allegedly threatening to infringe the patent for its multibillion-dollar diabetes drugs Januvia and Janumet.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Boehringer scores partial win in challenge to animal vaccine patents
Intellectual Property 2020-08-31 4:45 pm By Alison Eveleigh

German pharmaceutical giant Boehringer has partially succeeded in its opposition to several vaccine patents filed by animal health company Zoetis, used to treat pneumonia in pigs.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Landmark class action filed against Victoria over botched hotel quarantine program
COVID-19 2020-08-28 7:21 pm By Alison Eveleigh

The State of Victoria has been hit with a class action for its allegedly negligent handling of its hotel quarantine program, which is believed to be responsible for the state’s second wave of coronavirus cases.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

St Basil’s hit with class action over COVID-19 outbreak
COVID-19 2020-08-21 4:21 pm By Christine Caulfield

St. Basil’s in Victoria has become the latest aged care facility to face a class action over its allegedly negligent handling of the coronavirus pandemic.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court approves $2.9M penalty against HealthEngine for misleading reviews
Competition & Consumer Protection 2020-08-20 1:20 pm By Miklos Bolza

A court has approved a $2.9 million penalty against medical booking platform HealthEngine after the company admitted to deleting and altering unfavourable reviews and misusing consumer data.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Class action launched against Melbourne aged care home at centre of COVID-19 outbreak
COVID-19 2020-08-18 12:22 pm By Alison Eveleigh

The son of a 92-year-old woman who died after she contracted COVID-19 at a Melbourne aged care home has launched a class action against the residential facility, claiming damages for stress and anxiety caused by his mother’s death.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?